Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Copptech has developed over 30 patented formulations using copper and zinc-based antimicrobial technology that eliminates ≥99.9% of bacteria, viruses, fungi, mold, and even termites. Their solutions are incorporated into textiles, plastics, paints/coatings, packaging materials and more to provide long-lasting protection against pathogens. The company’s products are used by partners in Latin America, the US and Europe across multiple industries including healthcare-related applications for infection control. No clinical trial results as it is not a therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Copptech.